Xxera/openscience/retractions

Record #46354

Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systemativ review and meta-analysis

Anthéa Bertrand, Denis Gallot, Bruno Pereira, Amélie Delabaere

Journal

Current Research in Pharmacology and Drug Discovery

Publisher

Original paper date

Jun 1, 2023

Original DOI

10.1016/j.crphar.2022

Country

🇫🇷 France

Institution

CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France · Equipe, Translationnal Approach to Epithelial Injury and Repair, Université Clermont Auvergne, CNRS, Inserm, GReD, F-63000, Clermont-Ferrand, France · CHU Clermont-Ferrand, Biostatistics Unit (DRCI) Department, Clermont-ferrand, France · Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000, Clermont-Ferrand, France · Endocrinology Diabetology and Metabolic Diseases, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France · Institut Génétique, Reproduction & Développement (iGReD), CNRS, INSERM, University of Clermont, Auvergne, F-63000 Clermont-Ferrand, France

Open access

No

Article type

Meta-Analysis · Review Article

Broad categories

(HSC) Medicine - Diabetes (HSC) Medicine - Obstetrics/Gynecology (HSC) Medicine - Pharmacology

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

0

Post-retraction

1

% post-retraction

100.0%

~0.3 citations/yr after

— citing papers

Who is still citing this work

Loading…